Dr. Elizabeth Placzek, a pediatrician at Children’s Minnesota, explains how childhood vaccines are proven to be safe and effective at reducing serious illness and more.
There are two new FDA-approved options to prevent respiratory syncytial virus (RSV) in infants: a maternal RSV vaccine (Abrysvo) and a monoclonal antibody (nirsevimab; Beyfortus).
A new FDA-approved RSV preventative drug called Beyfortus could be a game-changer in the fight against RSV during the upcoming fall and winter. Learn more
Respiratory syncytial virus (RSV) is a major cause of respiratory illness in babies and young children every year from late fall to early spring. Learn
Get tips from the kid experts on how to keep your kids safe as cases of the flu and RSV rise.
Get information about where to get care for your child if they are experiencing respiratory illnesses like influenza, COVID-19 and respiratory syncytial virus (RSV).
“In my 30 years as a pediatric emergency physician at Children’s Minnesota, we’ve never seen this level of RSV illness in the middle of summer,”
Jordan and Jaare noticed their 5-week-old baby had labored breathing and later found out he had RSV at Children’s Minnesota. They dedicate much of their
Respiratory syncytial virus (RSV) spreads quickly and affects infants and young children. The trouble is, RSV can oftentimes be confused for the common cold or
Reach us 24/7 for patient referrals, consults, admissions and neonatal transport.
© 2024 Children’s Minnesota
Children’s Minnesota is registered as a 501(c)(3) non-profit organization. Our tax identification number is 41-1754276.
